It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

BioNTech

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand

National Feb 3, 2021

BioNTech 'confident' it will meet Japan's COVID-19 vaccine demand

Pfizer and BioNTech have increased manufacturing capacity to more than 2 billion doses a year from 1.3 billion to meet demand.

Taiwan asks Germany to help obtain coronavirus vaccines

Asia Pacific / Science & Health Jan 28, 2021

Taiwan asks Germany to help obtain coronavirus vaccines

The request comes after Berlin asked for the island's assistance in easing a shortage of automobile semiconductor chips.

Pfizer shot only slightly less effective against key South African mutations, study says

World Jan 28, 2021

Pfizer shot only slightly less effective against key South African mutations, study says

Pfizer Inc. and BioNTech's COVID-19 vaccine appeared to only lose a small bit of effectiveness against an engineered virus with three key mutations from the new variant found in South Africa, according to a laboratory study conducted by the U.S. drugmaker. The study by Pfizer ...

mRNA vaccines could vanquish COVID-19 today, cancer tomorrow

Commentary / World Jan 13, 2021

mRNA vaccines could vanquish COVID-19 today, cancer tomorrow

by Andreas Kluth

Therein lies mRNA’s bigger promise: It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides COVID-19.

How vaccine-makers are preparing for mutant coronavirus strains

World / Science & Health Dec 23, 2020

How vaccine-makers are preparing for mutant coronavirus strains

by Tim Loh

Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.

EU clears Pfizer COVID-19 vaccine for first inoculations

World Dec 22, 2020

EU clears Pfizer COVID-19 vaccine for first inoculations

Preparations for the vaccine roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain caused chaos across the region.

U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions

World / Science & Health Dec 10, 2020

U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions

Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.

With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout

World Dec 6, 2020

With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout

Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.

Why the U.K. approved a COVID-19 vaccine first

World / Science & Health Dec 3, 2020

Why the U.K. approved a COVID-19 vaccine first

by Benjamin Mueller

Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.

A triumph of German innovation and immigration

Commentary / World Dec 1, 2020

A triumph of German innovation and immigration

by Hans-werner Sinn

The great advantage of BioNTech's approach is that it allows for the production of more than one billion vaccine doses within the space of just a few months.

U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine

World / Science & Health Nov 29, 2020

U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine

The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus. Clearance is possible as soon as early next week, according to a person familiar ...

Pfizer vaccine's safety milestone is just the beginning

Commentary Nov 22, 2020

Pfizer vaccine's safety milestone is just the beginning

by Therese Raphael

As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.

« 1 2 3 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times